skip to content
Log in Sign up
Cart (0)
Phytomenadione, vitamin k deficiency treatment, KA VIT drops UK
Sale

Phytomenadione, vitamin k deficiency treatment, KA VIT drops

ELIVERA Buy online, Reviews Est. 1988 London, UK

£46.95 £50.00

Tax included. Shipping calculated at checkout.

KA VIT drops, Phytomenadione, vitamin k deficiency treatment

Phytomenadione, vitamin k deficiency treatment, KA-VIT ® drops


20 mg/ml emulsion to be taken in.

Active ingredient: phytomenadione (vitamin K1).

The only reliable area of ​​application for KA-VIT drops is the therapy of vitamin K deficiencies and the prevention of vitamin K deficiencies that cannot be remedied through nutrition.

For risks and side effects, read the leaflet and ask your doctor or pharmacist.

For the treatment of vitamin K deficiencies.

active Phytomenadione, vitamin k deficiency treatment, KA VIT drops ingredients

  • 20 mg phytomenadione

ingredients

  • disodium edetat-2 water
  • water, purified
  • Polysorbate 80
  • sorbic acid

 

Indication Phytomenadione, vitamin k deficiency treatment, KA VIT drops:

 

  • The preparation contains phytomenadione (vitamin K 1 ), an agent used to prevent bleeding.
  • The proven area of ​​application for the drug is the therapy of vitamin K deficiencies and the prevention of vitamin K deficiencies that cannot be remedied through nutrition. This includes:
    • Newborn vitamin K prophylaxis immediately after birth, vitamin K prophylaxis in patients with risk factors for the development of vitamin K deficiency as soon as the Quick value falls below the normal limit or the INR value rises above the normal limit,
    • Vitamin K therapy in patients with vitamin K deficiency bleeding, which is usually associated with a Quick value below 10% or an INR value of 5 or higher. Vitamin K deficiency bleeding can be caused by a real vitamin K deficiency or by overdosing on certain blood-thinning drugs (coumarin derivatives).
  • Evidence of risk factors for vitamin K deficiency
    • Risk factors in newborns and infants are:
      • Taking certain medicines (anticonvulsants, tuberculostatics and coumarin derivatives) during pregnancy and lactation
      • Premature birth and malnutrition, complicated birth, late start of feeding, exclusive feeding with breast milk and insufficient feeding.
    • Risk factors in infants, older children and adults are:
      • Impaired absorption of certain substances from the intestine (malabsorption syndrome), nutrition by direct infusion into the bloodstream (parenteral nutrition), accumulation of bile in the bile duct (bile duct atresia, alpha-1-antitrypsin deficiency, cystic fibrosis, cytomegalovirus infection, obstructive jaundice)
      • Diseases of the pancreas, reduced amount of certain proteins in the blood (A-ß-lipoproteinaemia), treatment with antibiotics (especially cephalosporins), sulphonamides or salicylates.
  • indications of deficiencies
    • Vitamin K deficiency symptoms can be caused
      • due to a real lack of vitamin K (e.g. due to diet or due to impaired absorption in the intestine)
      • when using anticoagulant drugs (coumarin derivatives such as phenprocoumon or warfarin) or due to various inhibitors of vitamin K1 epoxide reductase Signs of bleeding are bruising (haematomas), black-colored stools (tarry stool, melaena), red-colored stool due to bleeding urine (hematuria) and severe headache, dizziness or loss of symptoms due to bleeding in the brain.

 

Dosage Phytomenadione, vitamin k deficiency treatment, KA VIT drops:

 

  • Always take this medicine exactly as described or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
  • Use in newborns
    • How vitamin K 1 is used in newborns depends on what it is being given for and whether your baby was born prematurely.
  • Dosage to prevent vitamin K deficiency
    • Healthy newborns born on or near term receive:
      • a first dose of 2 drops (equivalent to 2 mg vitamin K 1 ) at or shortly after birth.
      • a second dose of 2 drops 3 to 10 days after birth
      • a third dose of 2 drops 4 to 5 weeks after birth
    • The third dose can be omitted for infants who are exclusively bottle-fed (with infant formula).
  • Premature babies or full-term babies with a particularly high risk of bleeding
    • These children should receive vitamin K 1 as a shot (injection). The drug is not suitable for this; Your doctor will use a different medicine for this.
  • Dosage for the treatment of vitamin K deficiency bleeding
    • In patients with vitamin K deficiency bleeding, the drug should be dosed according to the desired effect:
      • In the case of minor bleeding, a dose of 1 - 5 mg phytomenadione (equivalent to 1 - 5 drops) is generally sufficient, regardless of the patient's age.
      • In patients with vitamin K deficiency bleeding as a result of an overdose of anticoagulants (coumarin derivatives such as phenprocoumon or warfarin) who have light bleeding, stopping the anticoagulant is usually sufficient.
      • In the case of moderate bleeding, the administration of 5 - 10 mg phytomenadione (corresponding to 5 - 10 drops) is recommended.

 

  • duration of use
    • For long-term use, you should consult the doctor.

 

  • If you take more than you should
    • Even after overdosing, no toxic phenomena have been reported so far.

 

  • If you forget to take a dose
    • Do not take a double dose to make up for a forgotten dose.

 

  • If you stop taking it
    • Please talk to your doctor or pharmacist if you stop taking it. Under certain circumstances, the tendency to bleed may recur.

 

  • If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
way :
  • The drops are for oral use only.
  • It should be taken with some liquid.
  • You can dose the emulsion drop by drop by holding the bottle vertically downwards
Side effects :
  • Like all medicines, this medicine can cause side effects, although not everyone gets them.
  • The frequency of side effects is based on the following categories:
    • Very common: affects more than 1 in 10 people
    • Common: affects 1 to 10 users in 100
    • Uncommon: affects 1 to 10 users in 1,000
    • Rare: affects 1 to 10 users in 10,000
    • Very rare: affects less than 1 in 10,000 people
    • Not known: frequency cannot be estimated from the available data
  • In very rare cases, allergic (hypersensitivity) reactions to the active ingredient phytomenadione have been observed.
  • If you get any side effects, talk to your doctor or pharmacist. This also applies to side effects that are not specified.
Interactions :
  • When taking the preparation together with other medicines
    • Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines.
    • What other medicines affect the effect?
      • Medicines for blood clotting disorders (coumarin derivatives such as phenprocoumon or warfarin)
      • certain painkillers (acetylsalicylic acid (ASA) and other salicylates)
      • some antibiotics such as B. Cephalosporins can reduce the vitamin K effect or the effect of the drug.
    • Please note that this information may also apply to medicines that have been used for a short time.
      • Medicines used to treat seizures (antiseizure drugs such as phenobarbital and phenytoin) and medicines used to treat tuberculosis (anti-tuberculosis drugs such as isoniazid and rifampicin) can cause dangerous hypobleeding on the first day of life in newborn babies whose mothers took these medicines during pregnancy.
      • The long-term use of mineral oils (e.g. paraffinum liquidum) as well as the simultaneous intake of bile acid exchange resins (cholestyramine) and an agent for suppressing the body's own immune system (azathioprine) make it difficult to absorb vitamin K 1 .
    • How does the medicine affect the way other medicines work?
      • As an antidote, the preparation reverses the effect of anticoagulants.
Contraindications :
  • The drug must not be taken
    • if you are allergic to phytomenadione (vitamin K1 ) or any of the other ingredients of this medicine.
Pregnancy and lactation :
  • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
  • Previous experience with the intake of vitamin K 1 in pregnant and breastfeeding women has not shown any harmful effects in therapeutic doses.
Patient Notes :
  • Warnings and Precautions
    • Talk to your doctor or pharmacist before taking this medicine
      • if you regularly have to take medicines to treat blood clotting disorders (coumarin derivatives), you should only take the medicine if you strictly follow the dosage prescribed by your doctor. In this case, there is a risk of vascular occlusion (thrombosis) due to the coumarin effect being abolished, because the coagulation-promoting factors are activated more quickly by vitamin K 1 than the anticoagulant factors.

 

  • Ability to drive and use machines
    • Special precautions are not required.